计算机科学
可解释性
背景(考古学)
相关性(法律)
人工智能
药物开发
制药工业
人工智能应用
管理科学
风险分析(工程)
数据科学
药品
医学
工程类
药理学
古生物学
政治学
法学
生物
作者
Noorain,Varsha Srivastava,Bushra Parveen,Rabea Parveen
出处
期刊:Current Drug Metabolism
[Bentham Science]
日期:2023-09-01
卷期号:24 (9): 622-634
被引量:7
标识
DOI:10.2174/0113892002265786230921062205
摘要
Artificial Intelligence (AI) has emerged as a powerful tool in various domains, and the field of drug formulation and development is no exception. This review article aims to provide an overview of the applications of AI in drug formulation and development and explore its future prospects. The article begins by introducing the fundamental concepts of AI, including machine learning, deep learning, and artificial neural networks and their relevance in the pharmaceutical industry. Furthermore, the article discusses the network and tools of AI and its applications in the pharmaceutical development process, including various areas, such as drug discovery, manufacturing, quality control, clinical trial management, and drug delivery. The utilization of AI in various conventional as well as modified dosage forms has been compiled. It also highlights the challenges and limitations associated with the implementation of AI in this field, including data availability, model interpretability, and regulatory considerations. Finally, the article presents the future prospects of AI in drug formulation and development, emphasizing the potential for personalized medicine, precision drug targeting, and rapid formulation optimization. It also discusses the ethical implications of AI in this context, including issues of privacy, bias, and accountability.
科研通智能强力驱动
Strongly Powered by AbleSci AI